Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Read the Original
This page is a summary of: Successful use of IFN-γ for refractory systemic infection with Candida tropicalis in a child with AML and CARD9 mutation, Archives of Pathology and Clinical Research, June 2022, Heighten Science Publications Corporation, DOI: 10.29328/journal.apcr.1001031.
You can read the full text:
Be the first to contribute to this page